Regeneron links with Univ. of Colorado to sequence 450,000 patients for drug research

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 05/12/2020 at 11:50 am #4949
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster

    Regeneron Pharmaceuticals launched a new initiative that plans to sequence the DNA of 450,000 patients and compare the results with their health records, to support the company’s drug discovery and personalized medicine efforts.

    Find out more.

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.